The European Commission has updated its draft Q&A guideline on the EU Clinical Trials Regulation to clarify a range of issues, such as documentation and processes to be addressed in cases when a sponsor requests to extend an authorized clinical trial to another EU member state.
The draft guideline, which includes Q&As discussed progressively since December 2014, aims to support the implementation of the CTR (No...